The investments were a mix of issuance of guarantees ($ 742.80 million), loans ($ 303.48 million) and of equity ($ 207.39 million).

Agila Specialties, now a part of Mylan Inc, is recalling 10 lots of Etomidate injection, used in general anaesthesia in the US.

The pharmaceutical company said it has completed sale of its Agila Specialties Division to Mylan Inc for a total consideration of up to $1....

Strides Arcolab said it has completed the sale of its Agila Specialties division to Mylan Inc for a total consideration of up to $1.75 bill...

Strides Arcolabs' injectable drug division Agila Specialties Pharma Corporation has formed a 70:30 JV with Jamp Pharma to introduce injecta...

Strides Arcolab's wholly-owned subsidiary Agila Specialities acquired Sterile Formulations facility located at Hosur from Star Drugs and Re...

Shares of software exporters tumbled after US-based Oracle, the third biggest software maker, reported disappointing quarterly results.

Strides will soon choose between a private equity placement and a convertible bond issue to raise the first $125 million, a person familiar...

THE Bangalore-based pharma major, Strides Arcolab, saw its stock price rising by 8% on Wednesday on the back of news of the company collabo...

Strides Acrolabs is discussing drug supply deal for niche therapeutics areas with global drug pharma companies.

Private equity firm General Atlantic (GA) is in advanced talks with Strides Arcolabs to buy a significant minority stake in the Bangalore-b...

Hyderabad-based drug company Natco Pharma, which launched its anti-HINI drug 'Natflu' in the national capital, said it is talking with vari...

Ranbaxy Labs, Hetero Drugs and Strides Acrolabs have together bagged orders to supply 92-lakh capsules of generic or low-priced version of ...

Share price of drug companies Ranbaxy, Natco and Strides Acrolabs, that make low-priced versions of anti-flu medicine Tamiflu, surged on Tu...

Drug firm Strides Acrolab on Tuesday said it is in a position to supply Oseltamivir Capsules, the only available medicine against Influenza...

The Rs 1000 crore generic pharma company has received US FDA inspection approval status for its steriles injectable complex at Bangalore.

The Tata group is looking at a tie up with Microbotics, a US aerospace research and development company, to bring its products to India, an...